| Literature DB >> 27368338 |
Lyndal Henden1,2, Saskia Freytag1,2, Zaid Afawi3, Sara Baldassari4, Samuel F Berkovic5, Francesca Bisulli6,7, Laura Canafoglia8, Giorgio Casari9, Douglas Ewan Crompton10, Christel Depienne11,12, Jozef Gecz13,14, Renzo Guerrini15,16, Ingo Helbig17,18,19, Edouard Hirsch20, Boris Keren21,22, Karl Martin Klein23,24, Pierre Labauge25, Eric LeGuern22,26,27, Laura Licchetta6,7, Davide Mei15, Caroline Nava21,22, Tommaso Pippucci4, Gabrielle Rudolf11,28, Ingrid Eileen Scheffer5,29,30, Pasquale Striano31, Paolo Tinuper6,7, Federico Zara32, Mark Corbett13, Melanie Bahlo33,34.
Abstract
Familial adult myoclonus epilepsy (FAME) is a rare autosomal dominant disorder characterized by adult onset, involuntary muscle jerks, cortical myoclonus and occasional seizures. FAME is genetically heterogeneous with more than 70 families reported worldwide and five potential disease loci. The efforts to identify potential causal variants have been unsuccessful in all but three families. To date, linkage analysis has been the main approach to find and narrow FAME critical regions. We propose an alternative method, pedigree free identity-by-descent (IBD) mapping, that infers regions of the genome between individuals that have been inherited from a common ancestor. IBD mapping provides an alternative to linkage analysis in the presence of allelic and locus heterogeneity by detecting clusters of individuals who share a common allele. Succeeding IBD mapping, gene prioritization based on gene co-expression analysis can be used to identify the most promising candidate genes. We performed an IBD analysis using high-density single nucleotide polymorphism (SNP) array data followed by gene prioritization on a FAME cohort of ten European families and one Australian/New Zealander family; eight of which had known disease loci. By identifying IBD regions common to multiple families, we were able to narrow the FAME2 locus to a 9.78 megabase interval within 2p11.2-q11.2. We provide additional evidence of a founder effect in four Italian families and allelic heterogeneity with at least four distinct founders responsible for FAME at the FAME2 locus. In addition, we suggest candidate disease genes using gene prioritization based on gene co-expression analysis.Entities:
Mesh:
Year: 2016 PMID: 27368338 DOI: 10.1007/s00439-016-1700-8
Source DB: PubMed Journal: Hum Genet ISSN: 0340-6717 Impact factor: 4.132